Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation

被引:77
|
作者
Jamal, Janattul-Ain [2 ]
Economou, Caleb J. P. [2 ]
Lipman, Jeffrey [1 ,2 ]
Roberts, Jason A. [2 ,3 ]
机构
[1] Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Dept Intens Care Med, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld 4029, Australia
基金
英国医学研究理事会;
关键词
critical care; extracorporeal membrane oxygenation; pharmacokinetics; renal replacement therapy; sustained low-efficiency dialysis; CRITICALLY-ILL PATIENTS; CARE-UNIT PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; ACUTE KIDNEY INJURY; INTENSIVE-CARE; POPULATION PHARMACOKINETICS; DORIPENEM PHARMACOKINETICS; PEAK CONCENTRATION; SEPTIC PATIENTS; PHARMACODYNAMICS;
D O I
10.1097/MCC.0b013e32835685ad
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of review Antibiotic dosing for critically ill patients that is derived from other patient groups is likely to be suboptimal because of significant antibiotic pharmacokinetic changes, particularly in terms of drug volume of distribution and clearance. Organ support techniques including renal replacement therapy (RRT) and extracorporeal membrane oxygenation (ECMO) increase the pharmacokinetic variability. This article reviews the recently published antibiotic pharmacokinetic data associated with burns patients, those receiving continuous RRT (CRRT), sustained low-efficiency dialysis (SLED) and ECMO. Recent findings These groups develop increases in volume of distribution that necessitate the use of higher initial doses to rapidly achieve therapeutic antibiotic concentrations. Burns patients have supranormal drug clearances requiring more frequent administration of antibiotics. Patients receiving CRRT or SLED have variable drug clearances related to different equipment and RRT settings at different institutions. ECMO presents a different challenge because there is such a dearth of data with higher than standard doses potentially required, even in the presence of end-organ failure. Summary In the context of such variable pharmacokinetics, a guideline approach to dosing remains elusive because of insufficient available data and, therefore, use of therapeutic drug monitoring should be considered advantageous where possible.
引用
收藏
页码:460 / 471
页数:12
相关论文
共 50 条
  • [21] Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?
    Abdul-Aziz, Mohd H.
    Roberts, Jason A.
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (01) : 71 - 82
  • [22] Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software
    Roberts, Jason A.
    Bellomo, Rinaldo
    Cotta, Menino O.
    Koch, Birgit C. P.
    Lyster, Haifa
    Ostermann, Marlies
    Roger, Claire
    Shekar, Kiran
    Watt, Kevin
    Abdul-Aziz, Mohd H.
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (10) : 1338 - 1351
  • [23] Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software
    Jason A. Roberts
    Rinaldo Bellomo
    Menino O. Cotta
    Birgit C. P. Koch
    Haifa Lyster
    Marlies Ostermann
    Claire Roger
    Kiran Shekar
    Kevin Watt
    Mohd H. Abdul-Aziz
    [J]. Intensive Care Medicine, 2022, 48 : 1338 - 1351
  • [25] Connecting continuous renal replacement therapy in parallel with extracorporeal membrane oxygenation: is there no problem? Reply
    Lopez-Herce, Jesus
    Jose Santiago, Maria
    Sanchez, Amelia
    [J]. KIDNEY INTERNATIONAL, 2010, 77 (09) : 830 - 830
  • [26] Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation
    Cavagnaro, F.
    Kattan, J.
    Godoy, L.
    Gonzalez, A.
    Vogel, A.
    Rodriguez, J. I.
    Faunes, M.
    Fajardo, C.
    Becker, P.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (03): : 220 - 226
  • [27] EFFECT OF EARLY CONTINUOUS RENAL REPLACEMENT THERAPY WITH EXTRACORPOREAL MEMBRANE OXYGENATION ON NEONATAL NUTRITION
    Murphy, H.
    Cahill, J.
    Kiger, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 613 - 613
  • [28] Renal Replacement Therapy and Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients: The Devil Is in the Details
    Kumar, Nicolas
    Dorcius, Daphney
    Essandoh, Michael
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (06) : 1812 - 1813
  • [29] Prognostic factors in patients treated with extracorporeal membrane oxygenation and continuous renal replacement therapy
    Hiramatsu, Toshiki
    Shimizu, Shigemitsu
    Koga, Hidenobu
    [J]. PERFUSION-UK, 2022, 37 (06): : 570 - 574
  • [30] Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
    Pokorna, Pavla
    Michalickova, Danica
    Tibboel, Dick
    Berner, Jonas
    [J]. ANTIBIOTICS-BASEL, 2024, 13 (05):